A modern alternative to SparkNotes and CliffsNotes, SuperSummary offers high-quality Study Guides with detailed chapter summaries and analysis of major themes, characters, and more.
Summaries & Analyses
Quizzes
Reading Tools
Content Warning: This section of the guide includes discussion of illness, mental illness, emotional abuse, and gender discrimination.
In The New Perimenopause, Dr. Haver, challenges the view of the menopausal transition as a narrow gynecologic issue tied to irregular cycles and hot flashes. She reframes perimenopause as a systemic, brain-first neuroendocrine shift that reaches nearly every organ. Haver argues that this wider lens leads to clearer diagnosis and more effective care and pushes back against a medical culture that has treated midlife women through a fragmented approach. The transition begins in the brain, and its effects move outward to influence cognition, metabolism, bone strength, and cardiovascular health. Her holistic approach spreads across different concerns—such as mood, libido, and sleep—to demonstrate how hormonal changes have broad-reaching effects not typically associated with perimenopause. She argues that this interconnected perspective enables medical care that addresses the root cause of health concerns rather than merely treating symptoms.
One of Haver’s central points is that the brain registers hormonal disruption long before menstrual patterns change, which she states throughout the book: “Perimenopause doesn’t begin in the ovaries. It begins in the brain” (229). This already bridges the gap between the reproductive system, which can be alienated in treatment, and the core of the human body, which tends to receive more urgent attention. She explains that as the ovaries respond less predictably to hormonal cues, the pituitary gland changes its release of LH and FSH into a “new, disrupted pattern” (32). This neurological shift develops before any obvious change in bleeding patterns and shapes the earliest symptoms: anxiety, sleep problems, mood swings, and brain fog. According to Haver, these symptoms arise when altered serotonin and dopamine pathways combine with a slowdown in the brain’s glucose metabolism. By placing the brain at the start of the process, she moves perimenopause away from a narrow definition of reproductive aging and helps legitimize symptoms easily dismissed or blamed on women’s lifestyle choices.
From this point, Haver tracks how fluctuating and falling estrogen affects the rest of the body. She notes the wide spread of estrogen receptors in the heart, blood vessels, bones, and liver to show why estrogen loss heightens vulnerability across these systems. Without estrogen’s steadying influence, women face a rising risk for conditions that affect them in large numbers after menopause. Blood vessels stiffen, blood pressure climbs, and the chance of heart disease rises. Bone breakdown speeds up and sets the stage for osteoporosis. Metabolic changes push the body toward storing visceral fat. Haver uses these links to counter the idea that perimenopause resides only in the reproductive organs. Instead, she presents a moment in which multiple systems grow more fragile at once. By tying wide-ranging symptoms and risks to a shared hormonal cause, she outlines a whole-body approach to care that treats the perimenopausal woman as an interconnected system in the middle of a major biological shift.
Many women in midlife hear that new anxiety, depression, brain fog, or mood swings stem from stress or emotional strain, which often leads to antidepressant prescriptions. The New Perimenopause pushes back on this view. Haver instead argues that these cognitive and emotional changes often rise from biological turbulence during perimenopause. She builds a case that shifting estrogen and progesterone disrupt the brain’s chemistry and create a “hormone‑sensitive depression and anxiety phenotype” that differs from primary psychiatric illness (69). She therefore recommends considering MHT, especially transdermal estradiol, as a first-line treatment when mood and cognitive symptoms match the hormonal transition. In addressing how hormones impact one’s mood and cognitive function, Haver helps clarify and reaffirm women’s experiences, as well as offering a more impactful, direct route for treating and potentially overcoming their concerns.
Haver details the physiology behind this link. She describes estrogen and progesterone as neurosteroids that support neurotransmitters tied to mood, attention, and calm. Estrogen strengthens serotonin and dopamine pathways, which influence emotional steadiness and drive, while progesterone supports a calming effect. During perimenopause, as ovulation becomes irregular and estradiol levels swing sharply, this balance falls apart. Haver ties this instability to the increase in irritability, anxiety, and depression reported by up to 82% of perimenopausal women. By grounding these symptoms in the brain’s chemistry, she validates women’s experiences and pushes back on the idea that their distress is “all in [their] head” (40).
Haver’s account then critiques the widespread clinical habit of turning to SSRIs for perimenopausal mood symptoms without examining the hormonal cause. She notes that antidepressant use doubles for women during these years, although these drugs rarely address the neuroendocrine disruption driving the symptoms. This issue also applies to the increased diagnosis levels of ADHD in perimenopausal women, who experience attention-span issues, poor memory, and brain fog. As an alternative to antidepressants, she highlights evidence for hormone therapy and cites studies showing that when mood disorders begin during perimenopause, “estrogen should be considered a first-line therapy” (71), either alone or combined with psychiatric medication. This approach eases symptoms more effectively for many women and shifts treatment toward the biological source of the problem instead of masking its effects. In doing so, she both validates the experiences of patients and encourages them with actionable advice to help treat their issues rather than viewing them as permanent aspects of aging.
A recurring claim in The New Perimenopause is that women’s suffering during the menopausal transition often grows worse because clinicians dismiss or mislabel their symptoms. Haver calls this pattern “medical gaslighting.” She traces the problem to gender bias in training, weak diagnostic tools, and outdated guidelines that leave patients and clinicians without clear direction. By naming common dismissive comments and linking them to these systemic gaps, Haver affirms the experiences of many women and calls for care built on listening, stronger education, and respect for the patient’s lived reality. To help build her argument and highlight how women could be receiving improved care, she utilizes both personal anecdotes and medical research.
Haver opens with a direct look at a medical culture that has long explained women’s physical complaints as emotional strain. She admits that her own training carried the quiet assumption that “it’s all in her head” (xvi). She lists familiar lines addressed to midlife women, such as “You’re probably just stressed” or “Welcome to aging!” and reframes them as examples of medical gaslighting that undercut symptoms and delay care (40). This pattern hits especially hard during perimenopause, when fatigue, anxiety, and brain fog stretch across multiple systems. She notes how, despite the evidence of perimenopause’s impact on mental health, “there is no DSM-5 diagnostic category for perimenopause- or menopause-related depression. That absence sends a dangerous message: That this isn’t real. That it’s not worthy of clinical recognition” (69). In ignoring the issue, women internalize blame for their symptoms and fail to receive proper treatment. By giving this behavior a name and treating it as a real clinical issue, Haver helps patients see when their concerns are brushed aside and encourages them to seek fuller evaluation.
She then turns to the structural roots of the problem. Haver notes that clinicians lack a clear, symptom-based diagnostic tool for perimenopause and instead rely on menstrual irregularity, which often provides an incomplete picture. When a woman’s symptoms fall outside that narrow measure, clinicians may disregard them. Outdated guidelines last for years, and medical schools offer limited education on menopause, which leaves many clinicians without the training needed for complex cases. Chronic underfunding of women’s health research deepens these holes and leaves many basic questions about perimenopause unresolved. These combined gaps create a setting where dismissal becomes common and women must either endure their symptoms or look to unregulated and costly alternatives.
Haver provides numerous tools and extensive, accessible information on women’s health with the explicit goal of educating her readers and enabling them to overcome these systemic challenges. She refuses to allow her audience to internalize the blame for their prolonged or untreated symptoms, writing, “If navigating fertility during perimenopause feels challenging, it’s not because you’re not smart enough or dedicated enough or you don’t want it enough to figure it out; it’s because your body is no longer following the pattern you’ve known for decades. Period” (204). This firm, clear language helps ensure that her personal messages or professional advice aren’t lost within the pervasive, broader culture of ignoring or minimizing women’s health concerns, a system that coaches women to internalize shame and dismiss their own symptoms.



Unlock every key theme and why it matters
Get in-depth breakdowns of the book’s main ideas and how they connect and evolve.